1-4 of 4
Jeff Kaiser
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Patterns and Risk of CNS Recurrence after R-EPOCH Treatment for Double/Triple Hit Lymphoma

Mohammad Ahsan Sohail, MD, Hong Li, Wei Wei, MS, Sebastian Cerdena, PharmD, Marcus Watkins, PhD, Marissa Olson, PharmD, Gray Jodon, MD, Jeff Kaiser, PharmD, Bradley Haverkos, MD MPH, MS, Mitchell E. Hughes, PharmD, Natalie S Grover, MD, Anson Snow, MD, Victor M. Orellana-Noia, MD, Magdalena A Rainey, MS, Matthew J Cortese, MDMPH, Joslyn Rudoni, PharmD, Craig A. Portell, MD, Timothy J Voorhees, MD, Daniel J. Landsburg, MD, Manali Kamdar, MD MD, Brad S. Kahl, MD, Brian T. Hill, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 24–25.
https://doi.org/10.1182/blood-2020-142299
Published: 2020
Journal Articles

A Multi-Center Analysis of the Impact of Dose Level of R-EPOCH on Outcomes of Patients with Double/Triple-Hit B-Cell Lymphoma

Matthew J Cortese, MDMPH, Wei Wei, MS, Sebastian Cerdena, PharmD, Marcus Watkins, PhD, Marissa Olson, PharmD, Gray Jodon, MD, Jeff Kaiser, PharmD, Bradley Haverkos, MD MPH, MS, Mitchell E. Hughes, PharmD, Natalie S Grover, MD, Anson Snow, MD, Victor M. Orellana-Noia, MD, Magdalena A Rainey, MS, Mohammad Ahsan Sohail, MD, Joslyn Rudoni, PharmD, Craig A. Portell, MD, Timothy J Voorhees, MD, Daniel J. Landsburg, MD, Manali Kamdar, MD MD, Brad S. Kahl, MD, Brian T. Hill, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 32–34.
https://doi.org/10.1182/blood-2020-142958
Published: 2020
Journal Articles

Post Transplant Prophylaxis with High Dose Valacyclovir through Day 100 Versus Day of Post Transplant Hospital Discharge Decreases Cytomegalovirus Reactivation in Adult Umbilical Cord Blood Transplant Recipients

Prashant Sharma, MD, Jennifer MacDonald, Jeff Kaiser, Jennifer Tobin, Matthew Miller, Maheen Abidi, MD, Esther Benamu, MD, Enkhtsetseg Purev, MD PhD, Bradley M. Haverkos, MD MPH, MS, Jonathan A Gutman, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4659.
https://doi.org/10.1182/blood-2018-99-110211
Published: 2018
Journal Articles

An Outcome Study On Survival and Disease Control in Patients with High-Risk Multiple Myeloma (MM) for Relapse, Treated with High-Dose Melphalan Combined with Bortezomib for Autotransplant Followed by Post-Transplant Maintenance with Bortezomib and Lenalidomide.

Choon Kee Lee, MD, Jeff Kaiser, Pharm., D., Han Myint, FRCP, FRCPath, Mary Berg, MD, J. Fred Kolhouse, MD, William Robinson, MD
Journal: Blood
Blood (2009) 114 (22): 3404.
https://doi.org/10.1182/blood.V114.22.3404.3404
Published: 2009